KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Tax Provisions (2016 - 2025)

Thermo Fisher Scientific's Tax Provisions history spans 17 years, with the latest figure at $153.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Tax Provisions rose 2.0% year-over-year to $153.0 million, compared with a TTM value of $547.0 million through Dec 2025, down 16.87%, and an annual FY2025 reading of $547.0 million, down 16.74% over the prior year.
  • Tax Provisions for Q4 2025 was $153.0 million at Thermo Fisher Scientific, down from $207.0 million in the prior quarter.
  • The five-year high for Tax Provisions was $416.0 million in Q2 2021, with the low at $31.0 million in Q4 2022.
  • Average Tax Provisions over 5 years is $165.0 million, with a median of $151.5 million recorded in 2024.
  • Year-over-year, Tax Provisions skyrocketed 940.0% in 2021 and then plummeted 88.56% in 2022.
  • Tracing TMO's Tax Provisions over 5 years: stood at $203.0 million in 2021, then dropped by 14.78% to $173.0 million in 2022, then fell by 23.12% to $133.0 million in 2023, then increased by 12.78% to $150.0 million in 2024, then rose by 2.0% to $153.0 million in 2025.
  • Per Business Quant, the three most recent readings for TMO's Tax Provisions are $153.0 million (Q4 2025), $207.0 million (Q3 2025), and $92.0 million (Q2 2025).